Abstract-The effects of bradykinin on the regulatory mechanisms of prostacyclin synthesis in endothelial cells were investigated in association with intracellular Ca 2ϩ kinetics, cytosolic phospholipase A 2 (cPLA 2 ) activity, and mRNA expression of cPLA 2 and prostaglandin H synthase (PGHS) isoforms. Bradykinin enhanced prostacyclin release from endothelial cells time-dependently, but pretreatment with EGTA H-7 or HOE 140 inhibited bradykinin-induced prostacyclin release. Bradykinin increased both the influx of extracellular Ca 2ϩ and Ca 2ϩ release from the intracellular Ca 2ϩ storage sites. These reactions occurred within 5 minutes after bradykinin stimulation. Within 15 minutes, bradykinin activated cPLA 2 to 1.3-fold the control level. The constitutive expressions of mRNA of cPLA 2 , PGHS-1, and PGHS-2 was 87, 562, and 47 amol/g RNA, respectively. With the stimulation of bradykinin, cPLA 2 mRNA increased to 746 amol/g RNA in 15 minutes, PGHS-1 mRNA increased to 10 608 amol/g RNA, and PGHS-2 mRNA increased to 22 400 amol/g RNA in 180 minutes. Pretreatment with cycloheximide superinduced cPLA 2 and PGHS-2 mRNA expression but almost completely inhibited PGHS-1. Pretreatment with EGTA had effects similar to pretreatment with cycloheximide in the case of cPLA 2 and PGHS-1 but did not affect PGHS-2. These findings suggest that the elevation of cPLA 2 activity caused by the increase of intracellular Ca 2ϩ concentration is important in the early phase of bradykinin-induced prostacyclin synthesis and that the mechanisms regulating cPLA 2 are different from those regulating PGHS isoforms in endothelial cells. Key Words: bradykinin Ⅲ prostacyclin Ⅲ kinetics, calcium Ⅲ phospholipases A Ⅲ prostaglandin H synthase Ⅲ polymerase chain reaction B radykinin (BK) has blood pressure-lowering effects that can be induced by either the direct action of BK on target organs or the secretion of secondary agents. BK in plasma mainly acts on endothelial cells and stimulates them to release various agents associated with vascular tonus and blood coagulation, such as prostaglandins, endothelium-derived relaxation factor, catecholamines, and cytokines, resulting in the maintenance of circulation homeostasis. BK is resolved into inactive peptides by 2 kininases, carboxypeptidase N (kininase I) and dipeptide hydrase (kininase II). Kininase II is the same enzyme as angiotensin I-converting enzyme (ACE) and is secreted by endothelial cells. The clinical observation that ACE inhibitors lower blood pressure, even under low renin conditions, 1 suggests a renin-angiotensin system-independent mechanism for evoking their actions. From reports that the blood pressure-lowering effect of ACE inhibitors correlates with the increase of intravenous concentration of kinin and prostacyclin (prostaglandin I 2 , PGI 2 ), it appears that this mechanism is due to the local accumulation of BK and BK-induced vasodilators, especially PGI 2 , rather than to the reduction of vasoconstrictor angiotensin II; 2 however, the effects of ACE inhibition on BK and prostaglandins are unclear. PGI 2 is synthesized in response to release of arachidonic acid (AA) from phospholipids followed by transformation of AA to PGH 2 by prostaglandin H synthase (PGHSϭcyclooxygenase; COX) and subsequent transformation of PGH 2 by PGI 2 synthase. Recent studies have revealed that PLA 2 and PGHS have several isoforms and that many agents affect their expression at the level of genome transcription or protein translation. However, there have been few reports about the relation between BK-induced PGI 2 synthesis and signal transduction mechanisms in endothelial cells. In the present study, we investigated the effects of BK on the regulatory mechanisms of PGI 2 generation in human umbilical vein endothelial cells (HUVEC) with reference to intracellular Ca 2ϩ kinetics, cytosolic PLA 2 activity, and mRNA expression of cPLA 2 and PGHS isozymes.
B radykinin (BK) has blood pressure-lowering effects that can be induced by either the direct action of BK on target organs or the secretion of secondary agents. BK in plasma mainly acts on endothelial cells and stimulates them to release various agents associated with vascular tonus and blood coagulation, such as prostaglandins, endothelium-derived relaxation factor, catecholamines, and cytokines, resulting in the maintenance of circulation homeostasis. BK is resolved into inactive peptides by 2 kininases, carboxypeptidase N (kininase I) and dipeptide hydrase (kininase II). Kininase II is the same enzyme as angiotensin I-converting enzyme (ACE) and is secreted by endothelial cells. The clinical observation that ACE inhibitors lower blood pressure, even under low renin conditions, 1 suggests a renin-angiotensin system-independent mechanism for evoking their actions. From reports that the blood pressure-lowering effect of ACE inhibitors correlates with the increase of intravenous concentration of kinin and prostacyclin (prostaglandin I 2 , PGI 2 ), it appears that this mechanism is due to the local accumulation of BK and BK-induced vasodilators, especially PGI 2 , rather than to the reduction of vasoconstrictor angiotensin II; 2 however, the effects of ACE inhibition on BK and prostaglandins are unclear. PGI 2 is synthesized in response to release of arachidonic acid (AA) from phospholipids followed by transformation of AA to PGH 2 by prostaglandin H synthase (PGHSϭcyclooxygenase; COX) and subsequent transformation of PGH 2 by PGI 2 synthase. Recent studies have revealed that PLA 2 and PGHS have several isoforms and that many agents affect their expression at the level of genome transcription or protein translation. However, there have been few reports about the relation between BK-induced PGI 2 synthesis and signal transduction mechanisms in endothelial cells. In the present study, we investigated the effects of BK on the regulatory mechanisms of PGI 2 generation in human umbilical vein endothelial cells (HUVEC) with reference to intracellular Ca 2ϩ kinetics, cytosolic PLA 2 activity, and mRNA expression of cPLA 2 and PGHS isozymes.
Methods

Culture of HUVEC
Endothelial cells were obtained from human umbilical cord vein and cultured according to our previously described method. 3 We used primary cultured HUVEC that formed confluent monolayers in the following experiments. Cells were identified as vascular endothelial cells by electron microscopic findings of Weibel-Palade bodies in their cytoplasm and detection of ACE activity.
Assay of PGI 2 and Inositol 1,4,5-Trisphosphate Concentration
The concentration of PGI 2 and inositol 1,4,5-trisphosphate (IP 3 ) were measured with the use of previously described methods. 3 
Measurement of cPLA 2 Activity
After incubation in tissue culture medium (TCM) for 12 hours, the cells were scraped from the dish and collected into glass test tubes. The contents were centrifuged at 3000g for 5 minutes at 4°C. The cells were resuspended in TCM and centrifuged under the same conditions. The cells were finally suspended in TCM at a final concentration of 10 5 cells/mL and sonicated at 4°C for 3ϫ10 seconds. The sonicated cells were centrifuged at 3000g for 10 minutes to remove unlysed cells. The resulting lysate was then centrifuged at 10 000g for 60 minutes. The supernatant (soluble fraction) was transferred to another container and used as a source for the assay of cPLA 2 . The activity of cPLA 2 was measured by the method of Kramer, 4 with some modification. Each substrate was dried under nitrogen gas and suspended in distilled water by sonication at room temperature. The standard incubation system for the assay of cPLA 2 contained, in 0.25 mL, 50 mmol/L HEPES (pH 7.
Ϫ6 mol/L dioleoyl glycerol and enzyme preparation. The incubation was for 15 to 180 minutes at 37°C in the presence of BK (final concentration 10 Ϫ5 mol/L). The reaction was stopped by adding 1.25 mL of Dole's reagent. After 0.5 mL of H 2 O and 0.75 mL of n-heptane were added, the contents were spun in a vortex mixer for 5 minutes and centrifuged at 3000g for 5 minutes. An aliquot (0.8 mL) of the upper phase was pipetted into another tube containing 1 mL of heptane and 100 mg of silicic acid powder. After the tubes were shaken in a vortex mixer for 5 minutes and centrifuged as above, the heptane phase was transferred into scintillation vials. The radioactivity was measured by liquid scintillation spectrometry (TRI-CARB 460C Automatic Liquid Scintillation System, Packard Instrument Co Inc) with 10 mL of Atomlight (New England Nuclear) as a scintillator agent.
Measurement of Intracellular Ca 2؉ Concentration
Intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) was measured by the method of Grynkiewicz et al, 5 with some modification. The cells were scraped from the dish and collected in centrifugation tubes. After being suspended in 3 mL of buffer A containing 1.0% BSA, the cells were incubated in the presence of 3.2ϫ10
Ϫ6 mol/L fura-2/AM at 37°C for 45 minutes. After resuspension in 1.0% BSA-containing solution (cell count 10 6 /mL), they were centrifuged at 250g for 10 minutes. The fluorescence intensity from the endothelial cell suspensions then was recorded in UV-compatible cuvettes with a Ca 2ϩ analyzer (CAF-100: Japan Spectroscopic Co, Ltd) at excitation wave lengths of 340 nm and 380 nm and at an emission wavelength of 510 nm.
Ca
2؉ Uptake
After the cells were washed 3 times with buffer A, they were incubated with buffer A containing 1.85ϫ10 5 Bq/mL of 45 CaCl 2 (7.1484ϫ10 8 Bq/mg CaCl 2 , New England Nuclear) for 10 minutes. After incubation, the cells were washed 3 times with buffer A, and 1.0 mL of 6% trichloroacetic acid then was added to the dish. The cells were then rubbed off the dish with a rubber spatula, and the radioactivity of intracellular 45 Ca was measured by means of liquid scintillation spectrometry.
Measurement of Ca
2؉ Release From Ca
2؉
Storage Sites
First, the cells were scraped from the dish and permeabilized with saponin according to our previously described method. 3 The saponized HUVEC were subsequently incubated for 15 Primers used for genomic DNA (gDNA) amplification, reverse transcription, and for competitive polymerase chain reaction (PCR) were synthesized on the Gene Assembler Plus (Pharmacia LKB Biochrom Ltd). The sequences of 5Ј-and 3Ј-flanking oligonucleotide primers used for PCR amplification of gene and mRNA transcription were 5Ј-
, and 5Ј-GC-CCTTCACGTTATTGCAGAT-3Ј (PGHS-2-Rv).
RNA Isolation and Reverse Transcription
Total cellular RNA was isolated from HUVEC and was reverse transcribed to complementary DNA (cDNA) by Moloney murine leukemia virus reverse transcriptase according to our previously published method. 6 The concentrations of total RNA were determined by spectrophotometer at a 260-nm wave length.
Amplification of Genomic PGHS-1 DNA and Its Purification for Internal Standard of Competitive PCR
Genomic DNA samples were extracted from heparinized blood and amplified by PCR following the method of Saiki et al 7 With the use of the Gene ATAQ controller (Pharmacia LKB Biochrom Ltd), 40 PCR cycles were performed as follows: denaturation at 94°C for 1 minute, annealing at 62°C for 2 minutes, and extension at 72°C for 3 minutes. Five microliters of the reaction mixture containing the PCR product was subjected to electrophoresis on 2% agarose gel for confirmation of the product size. The remaining 195 L was loaded onto a 10% polyacrylamide gel (acrylamide/bis-acrylamide: vol/vol, 29:1) and electrophoresed for 40 minutes. The segment of the gel containing the DNA band was cut out by visualizing the ethidium-bromide-stained gels in longwavelength ultraviolet light. The gel slice then was transferred to a microfuge tube containing elution buffer (10 mmol/L Tris-HCl, pH 8.0, 1 mmol/L EDTA, 0.2% SDS, 0.3 mol/L NaCl). After the tube was incubated at 37°C for 12 hours, the supernatant was transferred to another microfuge tube. Two volumes of 100% ethanol were added to the tube at 4°C, and the tube was stored at Ϫ20°C for 30 minutes. The DNA was recovered as a pellet by centrifugation at 12 000g for 10 minutes at 4°C in a microfuge. Then the pellet was rinsed twice with 70% ethanol and redissolved in 50 L of dH 2 O.
Synthesis of Mutant-cDNA of cPLA 2 and PGHS-2 by Site-Directed Mutagenesis With PCR Used for Internal Standard of Competitive PCR
Complementary DNA of a mutant-cDNA of cPLA 2 and PGHS-2 were prepared by PCR-based, site-directed mutagenesis following the method of Higuchi et al. 8 The mutagenic primer of sequence 5Ј-GTGTTCTATTATGAGATTCTGAACTCCCCAGA-GAAAGC-TTGCTCTC-3Ј (PLA 2 -mFw), 5Ј-ATGTTCCACCCGCAGTACA-GAAAG-TATCACAAGCTT-3Ј (PGHS-2-mFw) was synthesized on the Gene Assembler Plus. Amplification of PLA 2 -or PGHS-2-cDNA with each mutagenic primer and Rv-primer by PCR showed a single change, C to T (italicized in PLA 2 -mFw) or G to A (italicized in PGHS-2-mFw), which created a unique Hind III site. The amplification and purification then were performed. ] gelatin). The PCR cycle was repeated 40 times following the protocol described above. Before loading the PCR products on gels for electrophoresis, cPLA 2 or PGHS-2 PCR products were digested by 10 U of Hind III for 60 minutes at 37°C. The PCR products of mutant-cDNA of cPLA 2 and PGHS-2 were divided into 2 fragments by Hind III digestion, but the PCR products of cDNA of native cPLA 2 and PGHS-2 did not have the Hind III-digested site. In this manner, competitive PCR products of native and mutant-cDNA of cPLA 2 and PGHS-2 were differentiated by digesting them with Hind III before electrophoresis. The samples then were loaded onto an 8% polyacrylamide gel (acrylamide/bis-acrylamide: vol/vol, 29:1) and analyzed by electrophoresis. The gel was stained with ethidium bromide (0.4 g/mL) and photographed. The bands corresponding to the amplified products of the internal standard (gDNA or digested mutant c-DNA) and mRNA were cut out, and their radioactivity was counted. The data were analyzed by plotting the logarithm of the gDNA cpm/cDNA cpm ratio as a function of the logarithm of the gRNA concentration.
Competitive PCR for Quantification of PGHS
Statistical Analysis
Data are expressed as meanϮSEM. ANOVA was used to make comparisons. For F ratios significant at the level of Յ5%, Duncan's multiple range test was applied to determine differences between any 2 groups. Differences of Յ5% (PϽ0.05) were considered statistically significant. Percent changes, for which a normal distribution cannot be assumed, were compared by means of the Kruskal-Wallis nonparametric method for ANOVA. Whenever the 2 test results were significant, the Mann-Whitney test was used to determine the significance of the differences between pairs of means.
Results
The addition of BK increased PGI 2 release dose-dependently at concentrations from 10 Ϫ10 mol/L through 10 Ϫ4 mol/L, and the release reached a plateau at the concentration of 10 Ϫ5 mol/L, so we used this concentration ( 89.5Ϯ23.7 amol/g RNA; however, the difference of PGHS-2 mRNA expression between control and EGTA pretreatment was not statistically significant ( Figure 4 ).
Discussion
ACE inhibitors are the most widely used drugs in the treatment of hypertensive patients. Their pharmacological effects depend not only on the reduction of the vasoconstrictor angiotensin II but also the local accumulation of kinins and kinin-related PGI 2 release, and the importance of the latter mechanisms has become apparent recently. Several kinds of BK-receptor subtypes have been identified and characterized according to their pharmacological and biochemical properties. Above all, the B 2 receptor is widely distributed over human tissues, especially smooth muscle cells and neurons, and mediates most of the cellular actions of BK. 9 In the present study, pretreatment with the B 1 -receptor antagonist des-Arg 9 -bradykinin did not inhibit the increase of BK-induced PGI 2 generation in HUVEC, but pretreatment with B 2 -receptor antagonist HOE 140 inhibited the BKinduced increase in HUVEC. The increased effect of BK on PGI 2 release was sustained for 3 hours after stimulation, but the increase rate of PGI 2 release declined after 15 minutes of BK stimulation. Because the concentration of BK in incubation fluid did not change from the beginning of incubation to 180 minutes after BK addition, this suggests that the cause of the rate of decline of PGI 2 release was not due to the reduction of BK concentration in incubation fluid but to other factors, for instance, downregulation of BK receptors induced by long-term exposure of BK. Pretreatment with the calcium chelator EGTA, PKC inhibitor H-7, PLC inhibitor U-73122, or DAG lipase inhibitor RHC80267 remarkably reduced BK-induced PGI 2 release, but the effects of the latter 2 inhibitors were more suppressive. These findings suggest that PLC and DAG affect BK-induced PGI 2 synthesis in HUVEC not only by PKC but also the PKC-independent pathway. From these results, we speculate that BK acts on HUVEC through B 2 receptors and that extracellular Ca 2ϩ and protein phosphorylation related to PKC, PLC, and DAG play important roles in the process of BK-induced PGI 2 synthesis.
The release of AA from phospholipids in the cell membrane is the first step of PGI 2 generation, and PLA 2 acts mainly in this step. PLA 2 has several isoforms. The genomic structures of type I and II of secretory PLA 2 (sPLA 2 ) and cytosolic PLA 2 (cPLA 2 ) have been determined. The release of AA from phospholipids of cell membranes is chiefly dependent on cPLA 2 and partially on sPLA 2 . 10 In the present study, BK elevated cPLA 2 activity to 132% of control within 15 minutes after stimulation, and this level of activity was maintained for 180 minutes. It is well known that cPLA 2 11 and that cPLA 2 translocates from cytoplasm to cell membrane in the gradient of [Ca 2ϩ ] i concentration. 12 It was also reported that the phosphorylation by MAP kinase raised PLA 2 activity to severalfold that of control. 13 These mechanisms raised cPLA 2 activity, thereby promoting the release of AA from membrane phospholipids and its subsequent conversion into PGI 2 through the PGHS pathway.
The synthesis of PGI 2 can also be controlled by altering the activity or expression of the enzyme. Because the increase effect of BK on PGI 2 generation is sustained for 3 hours after stimulation, we believe that not only the raise of enzymatic activity but also the quantitative increase of cPLA 2 or PGHS protein through mRNA transcription is involved in BKinduced PGI 2 synthesis in HUVEC. PGHS is another ratelimiting enzyme in the biosynthesis of prostanoids. Recently, 2 isoforms of PGHS, PGHS-1 (COX-1) and PGHS-2 (COX-2), were detected, and their gene structures and proteins were examined. PGHS-1 is expressed constitutively in most tissues, but PGHS-2 is highly and rapidly induced in response to cell activation. 14 In our present study, pretreatment with the PGHS-2 inhibitor NS-398 did not affect BK-induced PGI 2 release until 3 hours after BK stimulation, and the mRNA of PGHS-1, quantified by competitive PCR, was more markedly expressed than that of cPLA 2 or PGHS-2. This finding indicates that PGI 2 generation of the constitutive phase and early phase of BK stimulation in HUVEC depends on PGHS-1, not PGHS-2. The importance of PGHS-1 in the constitutive generation of prostanoids has been reported in most tissues including endothelial cells, 15 and our results support these findings.
The stimulation of BK provided interesting results. The mRNA expression of cPLA 2 increased to Ϸ8-fold that of control at 15 minutes after BK stimulation and maintained this level for 180 minutes. In contrast, that of PGHS-1 was unchanged until 60 minutes after BK stimulation but then had increased remarkably by 180 minutes. Although many investigators have evaluated the effects of substances on PGHS-1 mRNA expression, an increase of PGHS-1 mRNA was reported in a few studies, and their ratios of increase in expression of PGHS-1 mRNA were only Ϸ2-fold to 4-fold that of control level. 14 It was, therefore, assumed that the role of this enzyme was to produce prostaglandins that regulate normal cellular processes. Contrary to these former reports, in our study the level of PGHS-1 mRNA expression increased to Ϸ18-fold that of control at 180 minutes. Thus, it is possible that PGHS-1 acts as not only a constitutive enzyme but also an inducible enzyme in the regulation of PGI 2 synthesis in BK-stimulated HUVEC. The expression of PGHS-2 mRNA was only 44 amol/g RNA in an unstimulated HUVEC but had increased to Ϸ500-fold of control level at 180 minutes. The changes in PGHS-2 mRNA induced by BK were typical of an inducible enzyme. From our present findings, we speculate that there are 3 steps in the process of BK-induced PGI 2 synthesis in HUVEC. The first step is an immediate activation of cPLA 2 mediated by increase of intracellular Ca 2ϩ and protein phosphorylation of the already-existing enzyme. The second is a new synthesis of cPLA 2 protein by gene transcription. In these 2 steps, the main reaction is the supply of AA by cPLA 2 and the synthesis of PGI 2 by constitutively existing PGHS-1. The third step is the gene transcription and synthesis of new proteins of the PGHS isoforms. We observed no increase in PGHS-1 and PGHS-2 mRNA until 180 minutes. This time lag of BK-induced mRNA expression of cPLA 2 and PGHS isoforms is notable. It seems likely that cPLA 2 protein is generated by an induction of cPLA 2 mRNA before PGHS and provides PGHS with AA and that PGHS, which is synthesized belatedly for cPLA 2 , in turn synthesizes PGI 2 through the PGHS pathway. The newly synthesized cPLA 2 and PGHS proteins apparently act mainly in the later phase (after 180 minutes of BK stimulation) and maintain the sustained phase of PGI 2 generation. Their time course appears to be a reasonable reaction; however, we could not quantify the protein of cPLA 2 and PGHS. Further examinations to determine the relation of mRNA expression and protein synthesis are necessary.
To investigate the mechanism of intracellular signal transduction in BK-stimulated HUVEC, we evaluated the effects of cycloheximide and EGTA on mRNA expression. As speculated, BK stimulation under the condition of cycloheximide pretreatment remarkably increased the level of cPLA 2 and PGHS-2 mRNA expression in HUVEC. The cycloheximide-induced superinduction of cPLA 2 mRNA was previously reported in rat mesangial cells incubated with epidermal growth factor. 16 Cytosolic phospholipase A 2 mRNA, similar to immediate early genes, contains an AUrich sequence in its 3Ј-untranslated region, and cycloheximide superinduces immediate early genes by altering the stability of mRNA and inhibiting the synthesis of AU-binding factor, which increases the instability of mRNA. In the case of PGHS-2, cycloheximide also superinduces mRNA expression to about 90-fold that of the control level. Because PGHS-2 mRNA also contains an AU-rich sequence in its 3Ј-untranslated region, 14 mechanisms similar to those of cPLA 2 are thought to be involved in its cycloheximideinduced superinduction. Moreover, Srivastava et al 17 detected a new protein induced by interleukin-1␤ in rat mesangial cells and reported that this protein stabilizes PGHS-2 mRNA by binding its AU-rich region. Interestingly, the finding was completely different for PGHS-1 mRNA expression. As its expression is almost completely inhibited by cycloheximide, we speculate that there exists an enhancer protein that is indispensable for the transcription of PGHS-1 mRNA. In our present study, EGTA pretreatment inhibited the Ca 2ϩ influx by chelating extracellular Ca 2ϩ , resulting in a decrease in the BK-induced increase of [Ca 2ϩ ] i by Ϸ50%. Although the importance of intracellular Ca 2ϩ as a second messenger in intracellular signal transduction has been recognized, a detailed account of the relation between the second messenger, including intracellular Ca 2ϩ , and mRNA has not been provided. EGTA pretreatment increased cPLA 2 mRNA expression to the same extent as pretreatment with cycloheximide but decreased PGHS-1 mRNA expression to almost zero. The finding that PGHS-2 mRNA expression was not affected by EGTA pretreatment is unexpected because protein phosphorylation by PKC 18 or protein tyrosine kinase activation is causally linked to expression of mRNAs 19 and because some kinds of PKC isoforms are Ca 2ϩ -sensitive. The report that the Ca 2ϩ ionophore A23187 induces PGHS-2 mRNA expression in IL-1␤-stimulated chondrocytes 20 shows the important role of intracellular Ca 2ϩ in mRNA expression. The elucidation of these phenomena must await further investigations of the intracellular Ca 2ϩ -dependent signaling mechanisms involved with cPLA 2 and PGHS mRNA expression. This is the first report to investigate the effects of BK on the regulatory mechanisms of PGI 2 generation by cPLA 2 activity and the mRNA expression of cPLA 2 and PGHS isoforms in human vascular endothelial cells. We determined that the elevation of cPLA 2 activity caused by the increase of intracellular Ca 2ϩ concentration is an important event in the early phase of BK-induced PGI 2 synthesis, and we conclude that the mechanisms for the regulation of cPLA 2 and PGHS isoforms in endothelial cell are different. However, because we could not directly measure the protein and PGHS activity, further evaluations are needed to elucidate the regulatory mechanisms of BK-induced PGI 2 synthesis in HUVEC.
